SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : neog - Neogen's E.Coli Test adopted by Japan
NEOG 6.045-1.9%9:38 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rich H who wrote (360)9/16/1999 10:28:00 AM
From: Kramer  Read Replies (1) of 441
 
re /analyst estimates/ I did some checking around and the two companies, Roney & Hillard Lyons, that are covering neog have not posted estimates for this quarter. Roney & Hillard Lyons only have year end estimates for neog.

First Call's information is correct as they do not have an estimate posted for this quarter. However, Zacks appears to have a phantom estimate out there for 16 cents for this quarter, which as I mentioned earlier IMO has no basis.

BTW, neog will announce earnings September 30th.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext